CN104367926A - 一种治疗五更泻的中药制剂及其制备方法 - Google Patents
一种治疗五更泻的中药制剂及其制备方法 Download PDFInfo
- Publication number
- CN104367926A CN104367926A CN201410668887.1A CN201410668887A CN104367926A CN 104367926 A CN104367926 A CN 104367926A CN 201410668887 A CN201410668887 A CN 201410668887A CN 104367926 A CN104367926 A CN 104367926A
- Authority
- CN
- China
- Prior art keywords
- parts
- fructus
- chinese medicine
- spleen
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 122
- 206010012735 Diarrhoea Diseases 0.000 title claims abstract description 118
- 238000002360 preparation method Methods 0.000 title claims abstract description 63
- 210000003038 endothelium Anatomy 0.000 claims abstract description 16
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 229940079593 drug Drugs 0.000 claims description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 41
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 32
- 210000000582 semen Anatomy 0.000 claims description 30
- 241000756943 Codonopsis Species 0.000 claims description 23
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 22
- 239000010271 massa medicata fermentata Substances 0.000 claims description 21
- 239000000706 filtrate Substances 0.000 claims description 18
- 241000628997 Flos Species 0.000 claims description 17
- 230000008901 benefit Effects 0.000 claims description 17
- 241000244155 Taenia Species 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 15
- 239000000243 solution Substances 0.000 claims description 15
- 238000001914 filtration Methods 0.000 claims description 14
- 239000008187 granular material Substances 0.000 claims description 14
- 239000006187 pill Substances 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 11
- 230000002829 reductive effect Effects 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 9
- 238000004821 distillation Methods 0.000 claims description 8
- 239000002552 dosage form Substances 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 238000000108 ultra-filtration Methods 0.000 claims description 6
- 238000002425 crystallisation Methods 0.000 claims description 5
- 230000008025 crystallization Effects 0.000 claims description 5
- 238000002481 ethanol extraction Methods 0.000 claims description 5
- 239000012567 medical material Substances 0.000 claims description 5
- 229920001353 Dextrin Polymers 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 4
- 235000019425 dextrin Nutrition 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- -1 preparation Substances 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 235000011837 pasties Nutrition 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000009834 vaporization Methods 0.000 claims description 3
- 230000008016 vaporization Effects 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000008298 dragée Substances 0.000 claims description 2
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 230000008719 thickening Effects 0.000 claims description 2
- 210000000952 spleen Anatomy 0.000 abstract description 104
- 210000003734 kidney Anatomy 0.000 abstract description 83
- 230000000694 effects Effects 0.000 abstract description 54
- 238000010792 warming Methods 0.000 abstract description 45
- 230000001737 promoting effect Effects 0.000 abstract description 17
- 210000001835 viscera Anatomy 0.000 abstract description 8
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 230000003213 activating effect Effects 0.000 abstract description 4
- 230000003014 reinforcing effect Effects 0.000 abstract description 4
- 210000000936 intestine Anatomy 0.000 abstract description 3
- 241000132012 Atractylodes Species 0.000 abstract description 2
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 241000132446 Inula Species 0.000 abstract 1
- 244000116484 Inula helenium Species 0.000 abstract 1
- 235000002598 Inula helenium Nutrition 0.000 abstract 1
- 244000270834 Myristica fragrans Species 0.000 abstract 1
- 235000009421 Myristica fragrans Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 239000001702 nutmeg Substances 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 50
- 210000002784 stomach Anatomy 0.000 description 38
- 230000007812 deficiency Effects 0.000 description 37
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 33
- 201000010099 disease Diseases 0.000 description 30
- 208000002193 Pain Diseases 0.000 description 27
- 210000004072 lung Anatomy 0.000 description 23
- 206010047700 Vomiting Diseases 0.000 description 22
- 230000008673 vomiting Effects 0.000 description 19
- 206010000087 Abdominal pain upper Diseases 0.000 description 18
- 206010011224 Cough Diseases 0.000 description 18
- 230000001142 anti-diarrhea Effects 0.000 description 17
- 235000013305 food Nutrition 0.000 description 17
- 230000006870 function Effects 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 16
- 239000008280 blood Substances 0.000 description 16
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 15
- 208000019790 abdominal distention Diseases 0.000 description 15
- 201000006549 dyspepsia Diseases 0.000 description 14
- 206010062717 Increased upper airway secretion Diseases 0.000 description 13
- 210000001015 abdomen Anatomy 0.000 description 13
- 230000029087 digestion Effects 0.000 description 13
- 208000026435 phlegm Diseases 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 11
- 208000004998 Abdominal Pain Diseases 0.000 description 10
- 230000004087 circulation Effects 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 10
- 208000001848 dysentery Diseases 0.000 description 10
- 239000003172 expectorant agent Substances 0.000 description 10
- 230000003419 expectorant effect Effects 0.000 description 10
- 210000002216 heart Anatomy 0.000 description 10
- 230000014759 maintenance of location Effects 0.000 description 10
- 238000005728 strengthening Methods 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 238000012360 testing method Methods 0.000 description 9
- 230000036528 appetite Effects 0.000 description 8
- 235000019789 appetite Nutrition 0.000 description 8
- 230000003203 everyday effect Effects 0.000 description 8
- 208000000059 Dyspnea Diseases 0.000 description 7
- 206010013975 Dyspnoeas Diseases 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 7
- 206010003549 asthenia Diseases 0.000 description 7
- 210000000038 chest Anatomy 0.000 description 7
- 206010061428 decreased appetite Diseases 0.000 description 7
- 238000003745 diagnosis Methods 0.000 description 7
- 235000005911 diet Nutrition 0.000 description 7
- 230000035619 diuresis Effects 0.000 description 7
- 210000003414 extremity Anatomy 0.000 description 7
- 210000001624 hip Anatomy 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 241000700199 Cavia porcellus Species 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 5
- 230000002411 adverse Effects 0.000 description 5
- 239000003212 astringent agent Substances 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 210000002429 large intestine Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 231100000862 numbness Toxicity 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 210000003932 urinary bladder Anatomy 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000003187 abdominal effect Effects 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 208000019902 chronic diarrheal disease Diseases 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000004064 dysfunction Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 208000037920 primary disease Diseases 0.000 description 4
- 210000003296 saliva Anatomy 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 210000001113 umbilicus Anatomy 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 208000017667 Chronic Disease Diseases 0.000 description 3
- 208000002881 Colic Diseases 0.000 description 3
- 208000008967 Enuresis Diseases 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 206010041349 Somnolence Diseases 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 208000031975 Yang Deficiency Diseases 0.000 description 3
- 244000273928 Zingiber officinale Species 0.000 description 3
- 235000006886 Zingiber officinale Nutrition 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 208000022531 anorexia Diseases 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000002052 colonoscopy Methods 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 230000035617 depilation Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000008451 emotion Effects 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 230000001605 fetal effect Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 235000008397 ginger Nutrition 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000004064 recycling Methods 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 210000004916 vomit Anatomy 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 206010009900 Colitis ulcerative Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000011231 Crohn disease Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 206010016322 Feeling abnormal Diseases 0.000 description 2
- 206010016807 Fluid retention Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000001140 Night Blindness Diseases 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 206010039491 Sarcoma Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 201000006704 Ulcerative Colitis Diseases 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000004594 appetite change Effects 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- 239000000571 coke Substances 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 230000002951 depilatory effect Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 230000005176 gastrointestinal motility Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 208000002551 irritable bowel syndrome Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 150000002630 limonoids Chemical class 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 206010034754 petechiae Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- JVXZRQGOGOXCEC-UHFFFAOYSA-N scutellarein Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C(O)=C(O)C=C2O1 JVXZRQGOGOXCEC-UHFFFAOYSA-N 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- 241001506940 Alpinia japonica Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000209128 Bambusa Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 244000218454 Bambusa tulda Species 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 240000001829 Catharanthus roseus Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- UTPGJEROJZHISI-DFGCRIRUSA-N Gaillardin Chemical compound C1=C(C)[C@H]2[C@@H](OC(=O)C)C[C@@](C)(O)[C@@H]2C[C@@H]2C(=C)C(=O)O[C@H]21 UTPGJEROJZHISI-DFGCRIRUSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010018092 Generalised oedema Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000000857 Hepatic Insufficiency Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 241000798443 Hornodermoporus martius Species 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- VHLJDTBGULNCGF-UHFFFAOYSA-N Limonin Natural products CC1(C)OC2CC(=O)OCC23C4CCC5(C)C(CC(=O)C6OC56C4(C)C(=O)CC13)c7cocc7 VHLJDTBGULNCGF-UHFFFAOYSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241001081833 Myristicaceae Species 0.000 description 1
- 208000000592 Nasal Polyps Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 240000005827 Phyllostachys nigra Species 0.000 description 1
- 235000010717 Phyllostachys nigra Nutrition 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- UTPGJEROJZHISI-UHFFFAOYSA-N Pleniradin-acetat Natural products C1=C(C)C2C(OC(=O)C)CC(C)(O)C2CC2C(=C)C(=O)OC21 UTPGJEROJZHISI-UHFFFAOYSA-N 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 206010036018 Pollakiuria Diseases 0.000 description 1
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 1
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 208000006268 Sarcoma 180 Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 231100000132 chronic toxicity testing Toxicity 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000021551 crystal sugar Nutrition 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003866 digestant Substances 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000010135 fructus aurantii immaturus Substances 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 210000004317 gizzard Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 235000012171 hot beverage Nutrition 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 210000005246 left atrium Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 208000025036 lymphosarcoma Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000016366 nasal cavity polyp Diseases 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 206010029446 nocturia Diseases 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 208000023482 precordial pain Diseases 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000013139 quantization Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011127 radiochemotherapy Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000005982 spleen dysfunction Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 235000011844 whole wheat flour Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/754—Evodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗五更泻的中药制剂,其所述中药制剂的原料药的重量份数为:肉豆蔻10~20份,白术10~20份,益智仁10~20份,吴茱萸10~20份,补骨脂10~20份,茯苓10~20份,焦三仙10~20份,陈皮10~20份,肉桂10~20份,旋覆花10~20份,竹茹10~20份,山药10~20份,五味子10~20份,高良姜10~20份,砂仁10~20份,党参10~20份,厚朴10~20份,苍术10~20份,木香10~20份,鸡内金10~20份。本发明采用纯中药制剂,脾肾同治,温补肾阳的同时,也补脾益气,适合年老体衰者长期使用。本发明采用纯中药制剂,补五脏,温中健脾、清热利湿、运脾止泻,温肾暖脾,固肠止泻。本发明效果明显,且为纯正中药配伍,没有任何毒副作用,可以长期使用,并且见效快,治愈后不易复发。
Description
技术领域
本发明涉及含有来源于植物、动物或矿物原料的医用配制品,特别涉及一种治疗五更泻的中药制剂及其制备方法。
背景技术
五更泄,又名鸡鸣泄,肾泄。病因是由肾阳不足,命门火衰,阴寒内盛所致。中医认为,此病主要由于脾肾阳虚所致。患者除应注重腹部保暖、忌食生冷食物外,适当食疗亦可收到满意效果。病久渐虚,脾病损肾,则见脾肾阳虚。肾阳不足,命门火衰,不能蒸化致病。黎明之前,阴气盛,阳气未复,脾肾阳虚者,胃关不固,隐痛而作,肠鸣即泻,又称“五更泄”、“鸡鸣泄”;泻后腑气通则安;肾亏则腰膝酸冷,脘腹畏寒,形寒肢冷,四肢不温;肾阳虚衰,命门火衰,温煦无力,小便清长,夜间尿频;舌质淡,舌体胖有齿印,脉沉细无力,均为脾肾阳虚之征。
此症多见于由炎夏转入秋凉时期,男性多于女性,多见于中老年人。这类腹泻往往积年累月,给病人带来很大烦恼。证候表现:黎明泄泻,肠鸣脐痛,泻后痛减,大便稀薄,混杂不消食物,形寒肢冷,四肢不温,腰膝酸冷,疲乏无力,小便清长,夜尿频多。舌质淡,舌体胖、多有齿印,脉沉细无力。
五更泻是肾脾两脏的“同病”,它由肾阳虚衰,阳气不足,同时导致脾失温煦,运化失常。“五更”是指黎明前,此时不论是天时还是人体都乃一天的阳气至衰时,天时人体衰衰相投,弱弱共振,阴盛达到了极点。而此时又是阳气将萌之时,但是肾阳极虚者,肾虚不能行水,脾虚不能制水,于是,阴气极而下行,故发为泄泻,也即“五更泻”。其临床可见:每日黎明前肠鸣,腹泻,泻出稀溏大便2、3次,完谷不化,腹痛隐隐,若遇肥甘厚味之品而肠鸣腹泻加重、次数增多,同时,还常伴形寒肢冷,形体消瘦,面色萎黄,四肢困倦,舌质淡,苔白腻,脉沉弱。此为其主要临床表现。
西医认为五更泻是一个消化系统的慢性疾病,治疗十分棘手,往往事倍功半,甚至无效而终。而中医治疗也非一件易事,此为“肾脾同病”,中医日:穷必归肾,疾病若是“至虚到肾”,治疗起来已十分困难了。但是,十分困难并非无能为治,若诊疗得当,也可获得出乎意料的疗效。
关于五更泻的治疗,古人立有专方“四神丸”,(补骨脂、吴茱萸、肉豆蔻、五味子)。此方名“四神”,是指方中四药功效神速,“四神者,四种之药,治肾泻有神功也”(王晋三语)。但是,临床上,四神丸的疗效并非如此理想,它对一些病例有效,对另一些病例却无效,难以进行系统性规律性与普适性的把握。这很自然,中医若是离开了辩证施治,独守一法一方,效果可想而知但是,疾病的病情与症状的复杂的、多元的、千变万化的,具体问题具体对待。因而,在诊治疾病中必须这样。
发明内容
本发明所要解决的技术问题在于,西医认为五更泻是一个消化系统的慢性疾病,治疗十分棘手,往往事倍功半,甚至无效而终,西药多是抗生素、消炎药,毒副作用较大,且疗效不稳定,停药后易复发。而中医治疗也非一件易事,此为“肾脾同病”,中医日:穷必归肾,疾病若是“至虚到肾”,治疗起来已十分困难了,本发明脾肾同治,温补肾阳的同时,也补脾益气,适合年老体衰者长期使用。本发明温补脾肾,固肠止泻,效果明显,本发明纯正中药配伍,没有任何毒副作用,可以长期使用,并且见效快,治愈后不易复发。
为解决上述技术问题,本发明提供一种治疗五更泻的中药制剂,其所述中药制剂的原料药的重量份数可以为:肉豆蔻10~20份,白术10~20份,益智仁10~20份,吴茱萸10~20份,补骨脂10~20份,茯苓10~20份,焦三仙10~20份,陈皮10~20份,肉桂10~20份,旋覆花10~20份,竹茹10~20份,山药10~20份,五味子10~20份,高良姜10~20份,砂仁10~20份,党参10~20份,厚朴10~20份,苍术10~20份,木香10~20份,鸡内金10~20份。
所述治疗五更泻的中药制剂,其所述中药制剂的原料药的重量份数还可以为:肉豆蔻10~15份,白术10~15份,益智仁10~15份,吴茱萸10~15份,补骨脂10~15份,茯苓10~15份,焦三仙10~15份,陈皮10~15份,肉桂10~15份,旋覆花10~15份,竹茹10~20份,山药10~20份,五味子10~20份,高良姜10~20份,砂仁10~20份,党参10~20份,厚朴10~20份,苍术10~20份,木香10~20份,鸡内金10~20份。
所述治疗五更泻的中药制剂,其所述中药制剂的原料药的重量份数也可以为:肉豆蔻10~20份,白术10~20份,益智仁10~20份,吴茱萸10~20份,补骨脂10~20份,茯苓10~20份,焦三仙10~20份,陈皮10~20份,肉桂10~20份,旋覆花10~20份,竹茹10~15份,山药10~15份,五味子10~15份,高良姜10~15份,砂仁10~15份,党参10~15份,厚朴10~15份,苍术10~15份,木香10~15份,鸡内金10~15份。
为解决上述技术问题,本发明还提供一种治疗五更泻的中药制剂的制备方法,其所述中药制剂的剂型为丸剂,其制备步骤包括:
a、取原料药放入乙醇中浸泡24小时以上,热提取2次,成膏状,为组分1;
b、药渣加水提取2次,浓缩过滤为膏状,为组分2;
c、将上述两种膏状合并,浓缩成粉末加蜂蜜搓成丸剂。
所述步骤a中,可以取原料药泡入10倍量乙醇中浸泡24小时以上,然后加热回流提取2次,每次1~2小时,将2次提取液合并静置,去上清液,合并提取液,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,加热浓缩至膏状,静置备用,成为组分1。
所述步骤b中,可以将上述乙醇提取过的原料药的药渣加10倍量水,然后放入提取罐加热煮沸1小时,过滤,滤液备用;滤渣加水,第二次加热,煮沸45分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸半小时,过滤;将三次滤液合在一起,用纱布过滤,残渣中加入50-60%乙醇,60℃-70℃继续浸提2h,每10min搅拌一次,纱布过滤,合并浸提液,浓缩成糊状,成为组分2。
所述步骤c中,可以将组分1和组分2的浸膏合并,然后放入减压浓缩罐内,回收乙醇,浓缩至90℃时相对密度为1.05的浸膏,浓缩至每1ml含1g生药量,然后干燥成粉剂,加蜂蜜搓成丸剂。
为解决上述技术问题,本发明再提供一种治疗五更泻的中药制剂的制备方法,所述制剂的剂型为颗粒剂,制备方法包括:
先将肉豆蔻、肉桂、厚朴、苍术、木香、陈皮,用蒸馏法汽化,将上述药物蒸馏成结晶,干燥成细粉备用;再将蒸馏后的药渣颗粒与将所述剩余原料药,粉碎成颗粒,加水浸泡12小时;将浸泡好的原料置多功能提取罐中加水煎煮二次;第一次加总药材10倍量的水,煎煮1.5~2小时,取煎液,滤过;第二次加总量7倍量的水,煎煮1~1.2小时,取两次煎液混合,滤过;将过滤的滤液置入双效真空浓缩器中浓缩。
上述步骤中,浓缩进一步包括:
将上述步骤过滤的滤液置入双效真空浓缩器中,开始浓缩,浓缩至90℃时相对密度为1.05的浓缩液,加前述步骤得到的蒸馏结晶,加糊精调和,放入制粒机中制粒,装袋,使用时直接冲水。
所述治疗五更泻的中药制剂,其所述中药制剂的剂型可以为:糖衣片剂、薄膜衣片剂、肠溶衣片剂、硬胶囊剂、软胶囊剂、口服液、口含剂、颗粒剂、制剂、丸剂、散剂、丹剂、溶液剂或注射剂。
本发明有益技术效果在于:本发明能避免使用西药带来的副作用,西药多是抗生素、消炎药,对人体毒副作用较大,且疗效不稳定,停药后易复发。采用纯中药制剂,诸药合用,脾肾同治,温补肾阳的同时,也补脾益气,适合年老体衰者长期使用。能驱外邪,补五脏,温中健脾。本发明采用纯中药制剂,补五脏,温中健脾、清热利湿、运脾止泻,温肾暖脾,固肠止泻。本发明温补脾肾,固肠止泻,效果明显,且为纯正中药配伍,没有任何毒副作用,可以长期使用,并且见效快,治愈后不易复发。
具体实施方式
五更泻是肾脾两脏的“同病”,它由肾阳虚衰,阳气不足,同时导致脾失温煦,运化失常。“五更”是指黎明前,此时不论是天时还是人体都乃一天的阳气至衰时,天时人体衰衰相投,弱弱共振,阴盛达到了极点。而此时又是阳气将萌之时,但是肾阳极虚者,肾虚不能行水,脾虚不能制水,于是,阴气极而下行,故发为泄泻,也即“五更泻”。其临床可见:每日黎明前肠鸣,腹泻,泻出稀溏大便2、3次,完谷不化,腹痛隐隐,若遇肥甘厚味之品而肠鸣腹泻加重、次数增多,同时,还常伴形寒肢冷,形体消瘦,面色萎黄,四肢困倦,舌质淡,苔白腻,脉沉弱。此为其主要临床表现。
五更泻属于现代医学“非特异性溃疡性结肠炎”、“肠易激综合征”、“克罗恩病”、“慢性腹泻”范畴。中医学认为,五更泻多因泄泻日久,导致脾肾阳虚,五更之时阴气最盛,肾阳亏虚无力升阳,脾阳难受肾阳温煦,火不暖土而致腹痛肠鸣泄泻。本病临床表现为黎明之前脐下作痛,肠鸣即泻,泻后即安,或兼腹部畏寒,腰背酸冷,舌淡苔白,脉沉细弱。《景岳全书·泄泻》篇指出:“肾为胃关,开窍于二阴,所以二便之开闭,皆。肾脏之所主,今肾中阳气不足,命门火衰,而阴寒独盛,故子丑五更之后,当阳气未复,阴虚盛极之时,即令人洞泻不止也。”故本病应以脾肾阳虚为本,治疗当以温补脾肾为基本治法。诸药合用。共奏温肾暖脾止泻之效。现代药理研究证实,四神丸既可降低腹泻率与稀便率,又可明显减轻腹泻程度,表明本方具有良好的涩肠止泻功能。
党参、木香、益智仁等补气升阳药能增强机体免疫功能、调节胃肠运动,乌梅等收涩药有保护创面及黏膜、抗菌止泻作用。方中补骨脂、肉豆蔻、吴茱萸、五味子温肾暖脾,固肠止泻;高良姜温补脾肾;党参、白术、茯苓、补气健脾利湿;旋覆花涩肠止泻;厚朴、苍术升阳止泻。本发明温补脾肾,固肠止泻,效果明显,并且可以长期使用。
白术味苦、甘,温。归脾、胃经。主治健脾益气,燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。白术对瘤细胞有细胞毒作用,能降低瘤细胞的增殖率,减低瘤组织的侵袭性,提高机体抗肿瘤反应的能力。白术挥发油对小鼠艾氏腹水癌、淋巴肉瘤腹水型、食管癌(Ecal09)、肉瘤180等有抑制作用。白术内酯B腹腔注射对小鼠肉瘤民。也有显著抑制作用。《药性论》载其:君,味甘,辛,无毒。能主大风痹,多年气痢,心腹胀痛,破消宿食,开胃,去痰涎,除寒热,止下泄。主面光悦,驻颜,去黑。治水肿胀满,吐呕逆,腹内冷痛,吐泻不住,及胃气虚冷痢。
鸡内金:鸡内金是指家鸡的砂囊内壁,系消化器官,用于研磨食物,该品为传统中药之一,用于消化不良、遗精盗汗等症,效果极佳,故而以“金”命名。甘,寒。归脾、胃、小肠、膀胱经。消食健胃助消化,涩精止遗。可以促进胃液分泌,提高胃酸度及消化力,使胃运动功能明显增强,胃排空加快。《日华子本草》:止泄精,并尿血、崩中、带下、肠风、泻痢。《滇南本草》:宽中健脾,消食磨胃。治小儿乳食结滞,肚大筋青,痞积疳积。
益智仁味辛;性温,温肾固精缩尿,温脾开胃摄痰,主治脾胃虚寒;呕吐;泄泻;腹中冷育;口多唾涎;肾虚遗尿;尿频;遗精;白浊,多唾液等症。益智仁含挥发油、益智仁酮、维生素B1、维生素B2、维生素C、维生素E及多种氨基酸、脂肪酸等。益智仁煎剂具有健胃、抗利尿、减少唾液分泌的作用。其水提取物有抑制腹水型肉瘤S180。细胞增长的作用。其水提取物和乙醇提取物有抑制回肠收缩的作用。此外,其甲醇提取物有增强左心房收缩力、抑制氯化钾引起的免主动脉收缩和抑制前列腺素合成酶的活性等作用。肾虚遗尿、尿频者益智仁、乌药各等份。研为细末,酒煎山药未为糊,制丸如梧桐子大。每服9克,用淡盐汤或米饮送下,每日3次。或用盐炒益智仁、盐炒补骨脂各60克。共研为细末,分作6包,每天早晨以米汤泡服1包(成人加倍),6日为1个疗程。
五味子:五味子以根茎入药。具有补气养阴,健脾,润肺,益肾功能。用于治疗脾胃虚弱,体倦乏力,口干食少,肺虚燥咳,精血不足,内热消渴等症。对于糖尿病很有疗效。五味子具有降血压,降血糖,降血脂,防止动脉粥样硬化,延缓衰老和抗菌等作用,五味子多糖具有免疫激活作用。用于阴虚肺燥,干咳少痰,及肺肾阴虚的劳嗽久咳等。用于脾胃虚弱。既补脾阴,又益脾气,用于肾虚精亏得头晕,腰膝酸软,须发早白及消渴等。五味子壮筋骨,益精髓,变白发;适宜用于肺阴不足所致的咳嗽痰少,干咳无痰,咳血等症。
肉豆蔻为肉豆蔻科植物肉豆蔻的种仁,肉豆蔻别名豆蔻、肉果、迦拘勒、顶头肉、玉果、扎地、麻失,肉豆蔻有温中涩肠、行气消食的功效,肉豆蔻有治疗虚泻、冷痢、脘腹胀痛、食少呕吐、宿食不消的作用。性味:辛;苦;温。归经:脾;胃;大肠经。功效:温中涩肠;行气消食。主治:虚泻;冷痢;脘腹胀痛;食少呕吐;宿食不消。肉豆蔻食疗作用:肉豆蔻味辛、微苦,性温,有小毒,归脾、胃、大肠、肾经,芳辣香燥,可散可涩具有温中行气,涩肠止泻,开胃消食的功效
吴茱萸接近成熟的果实为常用中药。其性热味苦寒,有散热止痛、降逆止呕之功,用于治疗肝胃虚寒、阴浊上逆所致的头痛或胃脘疼痛等症。散寒止痛,降逆止呕,助阳止泻。用于厥阴头痛,寒疝腹痛,寒湿脚气,痛经,经行腹痛,脘腹胀痛,呕吐吞酸,五更泄泻,外治口疮;高血压。吴茱萸与干姜,均有温中散寒功效,治疗寒郁中焦,脘腹冷痛等证,二药常相须为用。然干姜尚能温上焦,温肺经化饮止咳;吴茱萸还能温下焦,温肝以治寒疝腹痛,助肾阳以治寒泻,温营血以治经闭。《本经》:主温中下气,止痛,咳逆寒热,除湿血痹,逐风邪,开腠理。《别录》:主痰冷,腹内绞痛,诸冷实不消,中恶,心腹痛,逆气,利五脏。
补骨脂味辛;味苦;性温归经:肾;心包;脾;胃;肺经功能主治:补肾助阳;纳气平喘;温脾止泻。主肾阳不足;下元虚冷;腰膝冷痛;阳痿精;尿频;遗尿;肾不纳气;虚喘不止;脾肾两虚;大便久泻。《本草经疏》:补骨脂,能暖水脏;阴中生阳,壮火益土之要药也。其主五劳七伤,盖缘劳伤之病,多起于脾肾两虚,以其能暖水脏、补火以生土,则肾中真阳之气得补而上升,则能腐熟水谷、蒸糟粕而化精微。脾气散精上归于肺,以荣养乎五脏,故主五脏之劳。七情之伤所生病。风虚冷者,因阳气衰败,则风冷乘虚而客之,以致骨髓伤败,肾冷精流,肾主骨而藏精,髓乃精之本,真阳之气不固,即前证见矣,固其本而阳气生,则前证白除。男子以精为主,妇人以血为主,妇人血气者,亦犹男子阳衰肾冷而为血脱气陷之病,同乎男子之肾冷精流也。
茯苓味甘、淡、性平,入药具有利水渗湿、益脾和胃、宁心安神之功用。现代医学研究:茯苓能增强机体免疫功能,茯苓多糖有明显的抗肿瘤及保肝脏作用。茯苓性味甘淡平,入心、肺、脾经。具有渗湿利水,健脾和胃,宁心安神的功效。可治小便不利,水肿胀满,痰饮咳逆,呕逆,恶阻,泄泻,遗精,淋浊,惊悸,健忘等症。茯苓之利水,是通过健运脾肺功能而达到的,与其它直接利水的中药不同。用于脾虚泄泻,带下茯苓既能健脾,又能渗湿,对于脾虚运化失常所致泄泻、带下,应用茯苓有标本兼顾之效,常与党参、白术、山药等配伍。有可用为补肺脾,治气虚之辅佐药。
焦三仙是三味药,即焦麦芽、焦山楂、焦神曲。这三味药均有良好的消积化滞功能,但又有各自不同的特点。焦麦芽有很好的消化淀粉类食物的作用;焦山楂善于治疗肉类或油腻过多所致的食滞;焦神曲则利于消化米面食物。三药合用,能明显地增强消化功能。因此,临床上医生常将三药合用并称为“焦三仙”。
麦芽,经大麦发芽而成,将麦芽置锅内微炒至黄色,喷洒清水,取出晒干,即为焦麦芽。焦麦芽具有健脾和胃、舒肝化滞之功,用于治疗食积不消、脘腹胀满、食欲不振、呕吐泄泻等症。现代研究认为,麦芽中富含淀粉分解酶、转化糖酶、脂化酶、维生素B等,有良好的助消化作用。
山楂,切片晒干,置锅内用武大炒至外面焦褐色、内部黄褐色为度、喷洒清水,取出晒干,即为焦山楂。口服山楂能增加消化酶,促进脂肪的分解和消化,对因吃肉类或油腻过多所致脘腹胀满、嗳气、不思饮食、腹痛、腹泻者,疗效尤佳。此外,现代药物试验表明,山楂有缓慢而持久的降低血压的功效,还可降低胆固醇和甘油三酯,防止动脉粥样硬化,而且还可舒张冠状动脉,增加心肌收缩力,对抗心律失常。因此,有利于防治高血压、高血脂、动脉硬化及冠心病。
神曲,为全麦粉和其他药物(青蒿、苍耳,辣蓼、杏仁、赤小豆等芽)混合后经发酵而成的加工品。取神曲置锅内炒至外表呈焦黑色、内部焦黄色,取出,喷洒些消水,放凉,即为焦神曲。神曲经发酵而成,凡发酵之品都有健脾胃助消化的作用,因此,对于饮食内伤所致的消化的不良、胸痞腹胀颇有效验。
陈皮温;辛、苦;归脾、肺经陈皮的苦味物质是以柠檬苷和苦味素为代表的“类柠檬苦素”,这种类柠檬苦素味平和,易溶解于水,有助于食物的消化。陈皮用于烹制菜肴时。其苦味与其他味道相互调和,可形成独具一格的风味。陈皮含有挥发油、橙皮甙、维生素B、C等成分,它所含的挥发油对胃肠道有温和刺激作用,可促进消化液的分泌,排除肠管内积气,增加食欲。陈皮也是一味常用中药,具有通气的健脾、燥湿化痰、解腻留香、降逆止呕的功效。
肉桂性大热,味辛、甘。归肾、脾、心、肝经。补火助阳,引火归源,散寒止痛,活血通经。暖脾胃,除积冷,通血脉。治命门火衰,肢冷脉微,亡阳虚脱,腹痛泄泻,寒疝奔豚,腰膝冷痛,经闭症瘕,阴疽,流注,及虚阳浮越,上热下寒。主治:用于阳痿、宫冷、心腹冷痛、虚寒吐泻、经闭、痛经、温经通脉。《别录》:主心痛,胁风,胁痛,温筋,通脉,止烦、出汗。主温中,利肝肺气,心腹寒热、冷疾,霍乱转筋,头痛,腰痛,止唾,咳嗽,鼻齆;能堕胎,坚骨节,通血脉,理疏不足;宣导百药,无所畏。《药性论》:主治九种心痛,杀三虫,主破血,通利月闭,治软脚,痹、不仁,胞衣不下,除咳逆,结气、拥痹,止腹内冷气,痛不可忍,主下痢,鼻息肉。杀草木毒。
旋覆花:味苦;辛;成;微温。归肺;胃;大肠经。降气,消痰,行水,止呕。用于风寒咳嗽,痰饮蓄结,胸膈痞满,喘咳痰多,呕吐噫气,心下痞硬。《神农本草经》:“主结气胁下满,惊悸。除水,去五脏间寒热,补中,下气。”现代研究,旋覆花对免疫性肝损伤有保护作用,其化学成分天人菊内酯有抗癌作用。此外,其根及茎叶或地上部分亦可入药,治刀伤、疔毒,煎服可平喘镇咳。《本草发明》:旋复花,消痰导饮、散结利气之味。其云除惊悸者,以去心下水饮,心神自定也。又治目中翳MIE头风,毕竟痰饮结滞而生风热,此能散之,头目自清也。
竹茹是中医药材,是禾本科植物青秆竹、大头典竹或淡竹的茎秆的干燥中间层。全年均可采制,取新鲜茎,除去外皮,将稍带绿色的中间层刮成丝条,或削成薄片,捆扎成束,阴干。前者称“散竹茹”,后者称“齐竹茹”。性味性微寒,味甘。功能主治:清热化痰,除烦止呕。用于痰热咳嗽、胆火挟痰、烦热呕吐、惊悸失眠、中风痰迷、舌强不语、胃热呕吐、妊娠恶阻、胎动不安。《别录》:主呕啘,温气寒热,吐血,崩中溢筋。《药性论》:止肺痿唾血,鼻衄,治五痔。
山药味甘、性平,入肺、脾、肾经;不燥不腻,有健脾补肺、益胃补肾、固肾益精、聪耳明目、助五脏、强筋骨、长志安神、延年益寿的功效;主治脾胃虚弱、倦怠无力、食欲不振、久泄久痢、肺气虚燥、痰喘咳嗽、肾气亏耗、腰膝酸软、下肢痿弱、消渴尿频、遗精早泄、带下白浊、皮肤赤肿、肥胖等病症。《本草纲目》概括五大功用“益肾气,健脾胃,止泄痢,化痰涎,润皮”。山药煮粥或者用冰糖煨熟后服用,对身体差、肠炎、肾亏等慢性病均有疗效。补益脾胃:治疗脾胃虚弱、泄泻、体倦、食少、虚汗。益肺滋肾:本品不寒不燥,味甘质润,可治疗肺肾虚损的消渴、遗精、带下等病证。被誉为神仙药
高良姜辛,热。归脾、胃经。功能主治温胃散寒,消食止痛。用于脘腹冷痛,胃寒呕吐,嗳气吞酸。高良姜在中国古代的诸多药典如《本草纲目》及《中国药典》均有记载。而在《图经本草》中则对高良姜有更详细的记载:“春生茎叶如姜苗而大,高一、二尺许,花红紫色如山姜”。高良姜对人体造血机能有显著促进作用,据《本草纲目》记载,“其性甘辣、清凉,除烦热、利津小便,通三焦团壅、塞气抗寒、散气之功效,且明目驱瘴。”其味辛,性温。有温胃散寒、行气、消食止痛之功效。主治脘腹寒痛、胃寒吐泻、消积食滞、消化不良等症。
砂仁(Fructus Amomi),是热带和亚热带姜科植物的的果实或种子,是中医常用的一味芳香性药材。中医认为,砂仁主要作用于人体的胃、肾和脾,能够行气调味,和胃醒脾。砂仁常与厚朴、枳实、陈皮等配合,治疗胸脘胀满、腹胀食少等病症。本草经疏》:“凡腹痛属火,泄泻得之暑热,胎动由于血热,咽痛由于火炎,小儿脱肛由于气虚,肿满由于湿热,上气咳嗽由于火冲迫肺而不由于寒气所伤,皆须详察鉴别,难以概用。”
党参为中国常用的传统补益药,古代以山西上党地区出产的党参为上品,具有补中益气,健脾益肺之功效。现代研究,党参含多种糖类、酚类、甾醇、挥发油、黄芩素葡萄糖甙、皂甙及微量生物碱,具有增强免疫力、扩张血管、降压、改善微循环、增强造血功能等作用。此外对化疗放疗引起的白细胞下降有提升作用。党参具有补中益气,健脾益肺的功效。用于脾肺虚弱,气短心悸,食少便溏,虚喘咳嗽,内热消渴等。《本草从新》记载:“补中益气、和脾胃、除烦渴。中气微弱,用以调补,甚为平妥。”
厚朴苦;辛;性温。归经:脾经;胃经;大肠经。功能:行气消积;燥湿除满;逆平喘。主治:食积气滞;腹胀便秘;湿阻中焦,脘痞吐泻;痰壅气逆;胸满喘咳,芳香化湿中药,主治:食积气滞;腹胀便秘;湿阻中焦,脘痞吐泻;痰壅气逆;胸满喘咳。出自《神农本草经》。本草经疏》:厚朴,主中风、伤寒头痛、寒热,气血痹死肌者,盖以风寒外邪,伤于阳分,则为寒热头痛;风寒湿入腠理,则气血凝涩而成痹,甚则肌肉不仁,此药辛能散结,苦能澡湿,温热能祛风寒,故悉主之也。《别录》又主温中、消痰、下气,疗霍乱,及腹痛胀满,胃中冷逆,胸中呕不止,泄痢心烦满者,何莫非肠胃气逆壅滞,及痰饮留结,饮食生冷所致。
苍术辛、苦,温。归脾、胃、肝经。主治:脾为湿困引起的运化失调,食欲不振,呕吐烦闷,腹胀泄泻,关节疼痛。苍术具有燥湿健脾,祛风湿的功效。主治湿阻中焦,风寒湿痹,脚膝肿痛,痿软无力,雀目夜盲。《珍珠囊》日:“能健胃安脾,诸湿肿非此不能除。”《本草纲目》曰:“治湿痰留饮......及脾湿下流,浊沥带下,滑泻肠风。”《新修本草》称其能“利小便”。
木香味辛,温。入心、肺、肝、脾、胃、膀胱六经。功效:行气,止痛,健脾,消食。主治:行气止痛;调中导滞。主胞胁胀满足;脘腹胀痛;嗳吐泄泻;痢疾后重。用于胸脘胀痛、泻痢后重、食积不消、不思饮食。1.脾胃气滞之脘腹胀满或疼痛,嗳气,恶心呕吐。2.湿浊中阻之胸闷腹胀,纳呆便溏。《纲目》:木香,乃三焦气分之药,能升降诸气。诸气膹郁,皆属于肺,故上焦气滞用之者,乃金郁则泄之也;中气不运,皆属于脾,故中焦气滞宜之者,脾胃喜芳香也;大肠气滞则后重,膀胱气不化则癃淋,肝气郁则为痛,故下焦气滞者宜之,乃塞者通之也。
本发明具体实施方式
具体实施例1
本发明胶囊剂的制备:取肉豆蔻1500g,白术1500g,益智仁1500g,吴茱萸1500g,补骨脂1500g,茯苓1500g,焦三仙1500g,陈皮1500g,肉桂1500g,旋覆花1500g,竹茹1500g,山药1500g,五味子1500g,高良姜1500g,砂仁1500g,党参1500g,厚朴1500g,苍术1500g,木香1500g,鸡内金1500g,取上述原料药加入5-10倍量的乙醇中浸泡24小时,加热提取2次,每次1-2小时,合并提取液,静置后去上清液,然后100-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,静置备用,成为组分1。将上述乙醇提取过的原料药的药渣加10倍量水,加热回流提取2次,每次1~2小时,将2次提取液合并静置;将上述两种提取液合并,减压回收乙醇并浓缩至药液浓度为0.6g生药/mL,抽滤后,滤液的相对密度约为20℃时1.08;浓缩至相对密度为1.20,温度至60℃-70℃的浸膏,静置备用,成为组分2。将组分1和组分2的浸膏合并,然后放入减压浓缩罐内,减压浓缩至相对密度为1.20,然后取出,放入烘干机烘干成粉末,放入胶囊中,成胶囊剂。
具体实施例2
本发明丸的制备:
取肉豆蔻1200g,白术1300g,益智仁1100g,吴茱萸1200g,补骨脂1100g,茯苓1200g,焦三仙1100g,陈皮1200g,肉桂1200g,旋覆花1100g,竹茹1100g,山药1200g,五味子1300g,高良姜1300g,砂仁1100g,党参1100g,厚朴1200g,苍术1200g,木香1200g,鸡内金1100g,取原料药泡入10倍量乙醇中浸泡24小时以上,加热提取2次,每次1-2小时,去上清液,合并提取液,静置后去上清液,然后放入减压浓缩罐内,减压回收乙醇,浓缩至药液浓度为0.6g生药/mL,抽滤至滤液的相对密度为20℃时1.06的浸膏,成为组分成组分1。将上述乙醇提取过的原料药的药渣加10倍量水,然后放入提取罐加热煮沸1小时,过滤,滤液备用;滤渣加水,第二次加热,煮沸45分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸半小时,过滤;将三次滤液合在一起,用纱布过滤,残渣中加入50-60%乙醇,60℃-70℃继续浸提2h,每10min搅拌一次,纱布过滤,合并浸提液,浓缩成糊状,成为组分2。将组分1和组分2的浸膏合并,然后放入减压浓缩罐内,回收乙醇,浓缩至相对密度为1.20,温度至60℃-70℃的浸膏,然后加热干燥成粉末,调入蜂蜜,搓成丸剂。
具体实施例3
本发明口服液剂的制备:
取肉豆蔻1100g,白术1100g,益智仁1200g,吴茱萸1100g,补骨脂1200g,茯苓1200g,焦三仙1100g,陈皮1200g,肉桂1200g,旋覆花1100g,竹茹1100g,山药1200g,五味子1300g,高良姜1300g,砂仁1100g,党参1200g,厚朴1100g,苍术1200g,木香1200g,鸡内金1200g,将原料药的药放入10倍量乙醇中,浸泡24小时,加热提取2次,每次1-2小时,合并提取液,静置后去上清液,然后放入减压浓缩罐内,减压回收乙醇,浓缩至药液浓度为0.6g生药/mL,抽滤至滤液的相对密度为20℃时1.06的浸膏,成为组分2。将组分1和组分2合并后置入双效真空浓缩器中,浓缩至90℃时相对密度为1.05的浓缩液,置0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含1g生药量;浓缩后的膏剂加糊精调和,紫外线消毒杀菌后装瓶。
具体实施例4
本发明颗粒剂的制备:先将肉豆蔻1200g,肉桂1100g,厚朴1200g,苍术1200g,木香1200g,陈皮1100g,用蒸馏法汽化,将上述药物蒸馏成结晶,干燥成细粉备用;再将蒸馏后的药渣颗粒与白术1100g,益智仁1200g,吴茱萸1100g,补骨脂1200g,茯苓1200g,焦三仙1100g,旋覆花1100g,竹茹1100g,山药1200g,五味子1200g,高良姜1100g,砂仁1100g,党参1200g,鸡内金1200g,粉碎成颗粒,加水浸泡12小时;将浸泡好的原料置多功能提取罐中加水煎煮二次;第一次加总药材10倍量的水,煎煮1.5~2小时,取煎液,滤过;第二次加总量7倍量的水,煎煮1~1.2小时,取两次煎液混合,滤过;将过滤的滤液置入双效真空浓缩器中浓缩膏,然后将上述步骤得到的白色结晶掺入浸膏中,加入糊精,调和;放入制粒机中制成颗粒剂,装袋。
药理学毒性试验
一、皮肤刺激实验
1、实验方法
将豚鼠背部脊柱两侧将脱毛剂均匀涂上,使去毛范围约20平方厘米。洗净脱毛剂归笼观察24小时,每组豚鼠分别涂本发明(丸剂)4、8和12g,分别含生药92mg、184mg和368mg,另一组涂溶媒0.8ml每日二次,连续一周,实验结束后,将豚鼠处死,心,肝,肾及脱毛皮肤做病理检验。
2、结果
上述三组用药豚鼠躯干脱毛区,未见局部皮肤有水肿、充血、红斑、出血点及溃疡。用药组豚鼠毛发色泽、摄食、四肢活动等对照组无明显差异,病理组织学检查,给药组心、肝、肾及脱毛皮与对照字比较也无明显差异。
结果提示,本发明无局部刺激作用,也未见全身毒性表现。表明本发明制剂使用安全。
二、动物急性毒性试验研究:
本发明经预试验,不能测出LD 50,故测定最大给药量。采用直肠给药途径,测得小鼠的一日最大给药量为62.7g/kg(以药粉计),约为拟临床人用量的1567.5倍(人以60kg计),大鼠的一日最大给药量62.7g/kg(以药粉计),约为拟临床人用量的1567.5倍。实验动物均连续观察一周,其外观体征、精神状态、饮食、饮水、粪便等均未见明显异常。实验结束时,动物均健康存活,体重增加。
三、动物长期毒性试验研究:
一、试验材料及方法
(一)受试药物:本发明实施例所制的片剂。
(二)实验动物,健康大鼠Wistar,体重100-130g,140只雌雄各半,按性别及体重随机分组,四组,每组35只。1、2、3组服用受试药物,剂量分别为9.6/kg/d,6.4/kg/d,3.2/kg/d。4组对照给相应体积量的蒸馏水、大鼠均灌胃肠给药,每组一次连用6个月,处死一半,佘下1/2停药观察12天全部死亡。
二、测试指标
(一)一般状况包括体重、饮食、情绪、活动能量。
(二)血象检查:红细胞计数、白细胞计数、血小板计数、血象等,血红蛋白定量计数。
(三)生化检查、血清蛋白定量、胆固醇、血糖定量。
(四)病理组织检查:实验结果后取半数动物称重,断头处死,取血,同时解剖心、肝、肾、肺、脑、脾、胃肠、膀胱、肾上腺做病理组织检查。
三、试验结果:经大鼠长期毒性试验表明,用本发明大剂量灌肠六个月,对大鼠的生长、体重增加、对脑、肝、肾功能均无毒副作用。对大鼠的各组织器官、循环系统未发现损害改变,用药组与对照组比较无明显差异。说明本发明药物具有温补肾阳、益气、补血、增强新陈代谢等药效,无毒性。
药物与临床实验
五更泻是一种慢性、反复发作性的黎明之时腹泻,又称晨泻、鸡鸣泻,其主要症状为每至黎明寅卯之时脘腹作痛或不痛,肠鸣即泻,泻后即安,病情缠绵难愈,严重危害患者的身心健康。本发明人在2010年7月~2012年10月采用温补脾肾法治疗五更泻患者50例。获得了较好临床效果,现报道如下:
1 资料与方法
1.1 一般资料
研究对象全部来自我院专科门诊和住院病例,按照纳入研究的先后,采用随机数字表法,将100例患者分为治疗组和对照组。治疗组50例,男28例,女22例;年龄25~70岁,平均45.8岁;病程最短0.5年,最长11年,平均4.6年。对照组50例,男27例,女23例;年龄26-71岁,平均46.6岁;病程最短0.5年,最长12年,平均5.2年。两组患者在性别、年龄、病程和病情轻重程度等方面比较差异无统计学意义(P>0.05),具有可比性。
1.2 诊断纳入、排除标准
根据《中医病证诊断疗效标准》中泄泻病肾虚证的诊断标准进行判定:①腹泻多发生在凌晨4:00~7:00,可伴现腹痛,便稀溏或夹杂未消化食物,甚则完谷不化,泻后痛减或消失,反复2~3次即止;②可伴有食少纳呆、腹胀、腰酸腿软、四肢不温、怕凉等;③病程至少半年以上,反复发作;④电子结肠镜检查可见结肠表面充血水肿、糜烂或出血点。纳入标准:①符合上述诊断标准的且年龄在25~70岁患者;②所有患者纳入研究前1周内均做过电子结肠镜检查;③停用中西药物治疗1周以上;④患者自愿参加本研究治疗。排除标准:①合并其他胃肠道疾病者;②电子结肠镜检查有结肠重度炎性改变者;③合并有严重心、脑、肝、肾、血液系统疾病及精神病患者;④妊娠或哺乳期妇女;⑤未按疗程用药或失访患者。
1.3 治疗方法
1.3.1 对照组采用温补脾肾法治疗,方选四神汤加减:补骨脂10g、吴茱萸10g、肉豆蔻10g、五味子15g、制附子9g、干姜9g、党参15g、白术15g、茯苓30g、升麻10g、黄芪20g、乌梅10g、金樱子20g、煨诃子10g、煨葛根30g、炙甘草10g。水煎服.每日2剂,疗程为4周。
1.3.3 治疗组,采用本发明中药制剂,方用:肉豆蔻13g,白术12g,益智仁14g,吴茱萸12g,补骨脂13g,茯苓12g,焦三仙12g,陈皮13g,肉桂14g,旋覆花12g,竹茹11g,山药13g,五味子13g,高良姜13g,砂仁12g,党参13g,厚朴12g,苍术13g,木香13g,鸡内金12g。水煎服.每日2剂,疗程为4周。
两组均加用艾灸神阙穴治疗。患者取仰卧位,充分暴露腹部。在神阙穴先放置食用盐。在盐上放置约0.2em厚的鲜生姜片,在鲜生姜上放置底径约1em,高1.5em的艾炷,点燃艾炷,使之燃尽,灸5-7壮,生姜片灸至无水分可更换。治疗期间禁食生冷、油腻之物。疗程为4周。
1.4 观察指标
按照《中药新药临床研究指导原则》闭中的症状量化分级标准,将患者治疗前后的临床表现(腹泻次数、大便变化、腹痛腹胀程度、食欲变化、乏力改善等)分为无、轻度、中度和重度,依次记0、1、2、3分。治疗过程中观察并统计治疗前后的积分变化
1.5 疗效评定
治愈:大便成形,次数正常,凌晨无腹痛、腹泻、肠鸣等症状。显效:大便呈膏状或稍稀,凌晨无腹痛、肠鸣等症状,次数明显减少或偶有腹泻。无效:大便稀溏或夹杂不化食物,凌晨仍存在腹痛、腹泻、肠鸣等症状。总有效=治愈+显效。
1.6 统计学方法
采用SPSS18.0对所得数据进行统计学分析,计量资料采用均数±标准差(X±S)表示,组间比较采用t检验,计数资料采用百分率表示,组间对比采用X2检验。以P<0.05为差异有统计学意义。
2 结果
2.1 两组疗效比较
治疗组治愈28例,显效14例,无效8例,总有效率为84%。对照组治愈21例,显效12例,无效17例,总有效率为66%,两组总有效率比较差异有统计学意义(P<0.05)。见表1。
表1 两组疗效比较(%)
组别 | 例数 | 治愈 | 显效 | 无效 | 总有效率 |
治疗组 | 50 | 28(56) | 14(28) | 8(16) | 84* |
对照组 | 50 | 21(42) | 12(24) | 17(34) | 66 |
注:与对照组比较,*P<0.05
2.2 两组治疗前后积分比较
治疗组治疗前后腹泻、腹胀腹痛、食欲变化、神疲乏力等症状积分比较差异有高度统计学意义(P<0.01)。对照组治疗前后腹泻、食欲变化、神疲乏力等症状积分比较差异有统计学意义(P<0.05),腹胀腹痛积分比较差异有高度统计学意义(P<0.01)。两组治疗后症状积分比较差异有统计学意义(P<0.05)。见表2。
表2 两组治疗前后积分比较(±s,分)
注:与同组治疗前比较,*p<0.05,**p<0.01;与对照组治疗后比较#p<0.05
3.讨论
五更泻属于现代医学“非特异性溃疡性结肠炎”、“肠易激综合征”、“克罗恩病”、“慢性腹泻”范畴。中医学认为,五更泻多因泄泻日久,导致脾肾阳虚,五更之时阴气最盛,肾阳亏虚无力升阳,脾阳难受肾阳温煦,火不暖土而致腹痛肠鸣泄泻。本病临床表现为黎明之前脐下作痛,肠鸣即泻,泻后即安,或兼腹部畏寒,腰背酸冷,舌淡苔白,脉沉细弱。《景岳全书·泄泻》篇指出:“肾为胃关,开窍于二阴,所以二便之开闭,皆。肾脏之所主,今肾中阳气不足,命门火衰,而阴寒独盛,故子丑五更之后,当阳气未复,阴虚盛极之时,即令人洞泻不止也。”故本病应以脾肾阳虚为本,治疗当以温补脾肾为基本治法。诸药合用。共奏温肾暖脾止泻之效。现代药理研究证实,四神丸既可降低腹泻率与稀便率,又可明显减轻腹泻程度,表明本方具有良好的涩肠止泻功能。
党参、木香等补气升阳药能增强机体免疫功能、调节胃肠运动,乌梅等收涩药有保护创面及黏膜、抗菌止泻作用。方中补骨脂、肉豆蔻、吴茱萸、五味子温肾暖脾,固肠止泻;高良姜温补脾肾;党参、白术、茯苓、补气健脾利湿;五味子涩肠止泻;厚朴、苍术升阳止泻。本发明温补脾肾,固肠止泻,效果明显,并且可以长期使用。
具体实施例1
李某,男,55岁,退休干部,该病人患黎明前腹泻3年佘,经多处诊治无效,于2010年7月15日来我处就诊,就诊时心情苦闷,情绪沮丧,已被病痛折磨得生不如死。自诉每日黎明之时,腹痛,肠鸣,泻肚2、3次,大便稀溏,完谷不化,更伴腹胀,常喜热饮,食欲不振,四肢困倦,形寒肢冷,面色萎黄,小便清长,舌质淡,苔白腻,脉搏沉弱。视其之前的治疗诸方,大多围绕着“四神丸”在转,却罔然无效。诊断:五更泻。治法:温补脾肾,固肠止泻。
选方:肉豆蔻13g,白术12g,益智仁14g,吴茱萸12g,补骨脂13g,茯苓12g,焦三仙12g,陈皮13g,肉桂14g,旋覆花12g,竹茹11g,山药13g,五味子13g,高良姜13g,砂仁12g,党参13g,厚朴12g,苍术13g,木香13g,鸡内金12g。服法:水煎服,每日1剂,日服4次,每次服200ml。20剂服后,上述症状全消,不仅身体康复,精神佳朗,而且心情彻底好转,恢复如常人,又巩固使用20剂,身强体壮,之后随访3年,未见复发。
具体实施例2
王某,60岁,男。2011年5月来诊。患者自述腹泻3年有佘,近1个月每日早晨6时左右即腹痛欲泻,大便清稀,泻后腹痛略有缓解。小便清长,口渴但是不喜饮水。常有嗳气,两胁胀满不舒。患者曾口服四神丸数月,但是未见明显效果。察看舌苔较干,舌质未见异常,但脉象弦数有力。辨证分析为肝郁犯脾、脾不运化所致,治以清热利湿、运脾止泻。药用痛泻要方加减:肉豆蔻11g,白术11g,益智仁14g,吴茱萸12g,补骨脂12g,茯苓12g,焦三仙12g,陈皮13g,肉桂14g,旋覆花12g,竹茹12g,山药13g,五味子13g,高良姜13g,砂仁12g,党参13g,厚朴12g,苍术11g,木香13g,鸡内金13g。服用10剂后腹痛腹泻减轻。又服用10剂,以进一步健脾祛湿,并服用逍遥丸以疏肝理气,共服药30剂月。患者腹痛腹泻消失,舌苔、脉象转向正常,至今未见复发。
Claims (10)
1.一种治疗五更泻的中药制剂,其特征在于,所述中药制剂的原料药的重量份数包括:肉豆蔻10~20份,白术10~20份,益智仁10~20份,吴茱萸10~20份,补骨脂10~20份,茯苓10~20份,焦三仙10~20份,陈皮10~20份,肉桂10~20份,旋覆花10~20份,竹茹10~20份,山药10~20份,五味子10~20份,高良姜10~20份,砂仁10~20份,党参10~20份,厚朴10~20份,苍术10~20份,木香10~20份,鸡内金10~20份。
2.根据权利要求1所述治疗五更泻的中药制剂,其特征在于,所述中药制剂的原料药的重量份数包括:肉豆蔻10~15份,白术10~15份,益智仁10~15份,吴茱萸10~15份,补骨脂10~15份,茯苓10~15份,焦三仙10~15份,陈皮10~15份,肉桂10~15份,旋覆花10~15份,竹茹10~20份,山药10~20份,五味子10~20份,高良姜10~20份,砂仁10~20份,党参10~20份,厚朴10~20份,苍术10~20份,木香10~20份,鸡内金10~20份。
3.根据权利要求1所述治疗五更泻的中药制剂,其特征在于,所述中药制剂的原料药的重量份数包括:肉豆蔻10~20份,白术10~20份,益智仁10~20份,吴茱萸10~20份,补骨脂10~20份,茯苓10~20份,焦三仙10~20份,陈皮10~20份,肉桂10~20份,旋覆花10~20份,竹茹10~15份,山药10~15份,五味子10~15份,高良姜10~15份,砂仁10~15份,党参10~15份,厚朴10~15份,苍术10~15份,木香10~15份,鸡内金10~15份。
4.一种如权利要求1~3中任一项所述治疗五更泻的中药制剂的制备方法,其特征在于,所述中药制剂的剂型为丸剂,其制备步骤包括:
a、取原料药放入乙醇中浸泡24小时以上,热提取2次,成膏状,为组分1;
b、药渣加水提取2次,浓缩过滤为膏状,为组分2;
c、将上述两种膏状合并,浓缩成粉末加蜂蜜搓成丸剂。
5.根据权利要求4所述治疗五更泻的中药制剂的制备方法,其特征在于,所述步骤a中,取原料药泡入10倍量乙醇中浸泡24小时以上,然后加热回流提取2次,每次1~2小时,将2次提取液合并静置,去上清液,合并提取液,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,加热浓缩至膏状,静置备用,成为组分1。
6.根据权利要求4所述治疗五更泻的中药制剂的制备方法,其特征在于,所述步骤b中,将上述乙醇提取过的原料药的药渣加10倍量水,然后放入提取罐加热煮沸1小时,过滤,滤液备用;滤渣加水,第二次加热,煮沸45分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸半小时,过滤;将三次滤液合在一起,用纱布过滤,残渣中加入50-60%乙醇,60℃-70℃继续浸提2h,每10min搅拌一次,纱布过滤,合并浸提液,浓缩成糊状,成为组分2。
7.根据权利要求4所述治疗五更泻的中药制剂的制备方法,其特征在于,所述步骤c中,将组分1和组分2的浸膏合并,然后放入减压浓缩罐内,回收乙醇,浓缩至90℃时相对密度为1.05的浸膏,浓缩至每1ml含1g生药量,然后干燥成粉剂,加蜂蜜搓成丸剂。
8.一种如权利要求1~3中任一项所述治疗五更泻的中药制剂的制备方法,其特征在于,所述制剂的剂型为颗粒剂,制备方法包括:
先将肉豆蔻、肉桂、厚朴、苍术、木香、陈皮,用蒸馏法汽化,将上述药物蒸馏成结晶,干燥成细粉备用;再将蒸馏后的药渣颗粒与将所述剩余原料药,粉碎成颗粒,加水浸泡12小时;将浸泡好的原料置多功能提取罐中加水煎煮二次;第一次加总药材10倍量的水,煎煮1.5~2小时,取煎液,滤过;第二次加总量7倍量的水,煎煮1~1.2小时,取两次煎液混合,滤过;将过滤的滤液置入双效真空浓缩器中浓缩。
9.根据权利要求8中任一项所述治疗五更泻的中药制剂的制备方法,其特征在于,上述步骤中,浓缩进一步包括:
将上述步骤过滤的滤液置入双效真空浓缩器中,开始浓缩,浓缩至90℃时相对密度为1.05的浓缩液,加前述步骤得到的蒸馏结晶,加糊精调和,放入制粒机中制粒,装袋,使用时直接冲水。
10.根据权利要求1~9任一项所述治疗五更泻的中药制剂,其特征在于,所述中药制剂的剂型为:糖衣片剂、薄膜衣片剂、肠溶衣片剂、硬胶囊剂、软胶囊剂、口服液、口含剂、颗粒剂、制剂、丸剂、散剂、丹剂、溶液剂或注射剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410668887.1A CN104367926A (zh) | 2014-11-20 | 2014-11-20 | 一种治疗五更泻的中药制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410668887.1A CN104367926A (zh) | 2014-11-20 | 2014-11-20 | 一种治疗五更泻的中药制剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104367926A true CN104367926A (zh) | 2015-02-25 |
Family
ID=52547286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410668887.1A Pending CN104367926A (zh) | 2014-11-20 | 2014-11-20 | 一种治疗五更泻的中药制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104367926A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105663968A (zh) * | 2016-04-09 | 2016-06-15 | 乔兴友 | 一种治疗脾肾阳虚型肠易激综合症的中药组合物 |
CN107213449A (zh) * | 2017-07-04 | 2017-09-29 | 金云龙 | 一种用于治疗五更泻的中药制剂 |
CN108851070A (zh) * | 2018-08-21 | 2018-11-23 | 吕艳波 | 药膳羊肚及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103041360A (zh) * | 2013-01-16 | 2013-04-17 | 李郑生 | 一种治疗功能性腹泻和肠易激综合征的口服液 |
CN103520681A (zh) * | 2013-10-18 | 2014-01-22 | 河南中医学院 | 一种治疗脾肾阳虚型慢性结肠炎的中药 |
-
2014
- 2014-11-20 CN CN201410668887.1A patent/CN104367926A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103041360A (zh) * | 2013-01-16 | 2013-04-17 | 李郑生 | 一种治疗功能性腹泻和肠易激综合征的口服液 |
CN103520681A (zh) * | 2013-10-18 | 2014-01-22 | 河南中医学院 | 一种治疗脾肾阳虚型慢性结肠炎的中药 |
Non-Patent Citations (2)
Title |
---|
严付红: "调肝扶脾益肾汤治疗腹泻型肠易激综合征38例", 《河南中医》 * |
李江文: "中药口服联合灌肠治疗溃疡性结肠炎 108 例", 《光明中医》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105663968A (zh) * | 2016-04-09 | 2016-06-15 | 乔兴友 | 一种治疗脾肾阳虚型肠易激综合症的中药组合物 |
CN107213449A (zh) * | 2017-07-04 | 2017-09-29 | 金云龙 | 一种用于治疗五更泻的中药制剂 |
CN108851070A (zh) * | 2018-08-21 | 2018-11-23 | 吕艳波 | 药膳羊肚及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103099959B (zh) | 一种治疗溃疡性结肠炎的中药制剂及其制备方法 | |
CN102988870A (zh) | 一种治疗肝胆胃肠道疾病的口服液 | |
CN104146261A (zh) | 一种妇女更年期的中药保健品及其制备方法 | |
CN104491755A (zh) | 一种治疗腹胀的中药组合物及其制备方法 | |
CN104940740A (zh) | 一种治疗多囊卵巢综合征的中药组合物及其制备方法 | |
CN103749821B (zh) | 一种提高免疫力的绞股蓝保健茶及其制备方法 | |
CN105311581A (zh) | 一种预防和治疗乳腺增生的中药组合物及其制备方法 | |
CN105664099A (zh) | 一种温补肾阳的中药组合物及其制备方法 | |
CN104367926A (zh) | 一种治疗五更泻的中药制剂及其制备方法 | |
CN104353051A (zh) | 一种治疗胃痛的中药制剂及其制备方法 | |
CN104815232A (zh) | 一种治疗原发性肺动脉高压的中药制剂及其制备方法 | |
CN104524479B (zh) | 一种治疗经前期综合征的中药组合物及其制备方法 | |
CN104042981A (zh) | 一种治疗产后便秘的药剂及制备方法 | |
CN104353043A (zh) | 一种治疗五更泻的中药组合物及其制备方法 | |
CN105343866A (zh) | 一种用于治疗寒饮咳嗽的中药片剂及制备方法 | |
CN105435190A (zh) | 用于治疗寒热错杂型哮病的中药组合物及其制备方法 | |
CN104857370A (zh) | 一种治疗乳腺癌症的中药组合物 | |
CN104800780A (zh) | 一种治疗多囊卵巢综合征的中药制剂及其制备方法 | |
CN105106916A (zh) | 一种产后护理用中药 | |
CN104523929A (zh) | 一种治疗感冒的中药组合物及其制备方法与应用 | |
CN114712466B (zh) | 一种具有减肥养颜功效的药物及其制备方法 | |
CN105012637A (zh) | 一种治疗乳腺肿瘤的药物 | |
CN105343508A (zh) | 一种制备治疗更年期综合征的中药组合物的方法 | |
CN104888091A (zh) | 一种治疗肠型急性放射病的中药组合物及其制备方法 | |
CN104857371A (zh) | 一种治疗结肠癌的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150225 |
|
RJ01 | Rejection of invention patent application after publication |